 | • レポートコード：MRC2304J0229 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、222ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料によると、世界のバイオリアクター市場規模は、2021年1,571.95百万ドルから2022年に1,717.08百万ドルへと拡大、その後2027年までに年平均9.37％成長して2,691.64百万ドルに達する見通しです。本書は、バイオリアクターの世界市場を対象とした調査・分析結果を整理したものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、用途別分析（本格生産、研究室規模生産、パイロット規模生産）、制御タイプ別分析（自動式、手動式）、材料別分析（ガラス、ステンレス鋼）、メカニズム別分析（エアリフト型バイオリアクター、ベンチトップ型バイオリアクター、気泡塔型バイオリアクター、連続攪拌タンク型バイオリアクター、流動層型バイオリアクター）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目を掲載しています。なお、本書には、3D Biotek LLC、Applikon Biotechnology BV、BBI-Biotech GmbH、Bioengineering AG、Broadley-James Corporation、Cell Culture Company、Cytiva、Eppendorf AG、GEA Group AG、Infors AG、Merck KGaA、Pall Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のバイオリアクター市場規模：使用法別 - 本格生産における市場規模 - 研究室規模生産における市場規模 - パイロット規模生産における市場規模 ・世界のバイオリアクター市場規模：制御タイプ別 - 自動式バイオリアクターの市場規模 - 手動式バイオリアクターの市場規模 ・世界のバイオリアクター市場規模：材料別 - ガラスの市場規模 - ステンレス鋼の市場規模 ・世界のバイオリアクター市場規模：メカニズム別 - エアリフト型バイオリアクターの市場規模 - ベンチトップ型バイオリアクターの市場規模 - 気泡塔型バイオリアクターの市場規模 - 連続攪拌タンク型バイオリアクターの市場規模 - 流動層型バイオリアクターの市場規模 ・世界のバイオリアクター市場規模：地域別 - 南北アメリカのバイオリアクター市場規模 アメリカのバイオリアクター市場規模 カナダのバイオリアクター市場規模 ブラジルのバイオリアクター市場規模 ... - アジア太平洋のバイオリアクター市場規模 日本のバイオリアクター市場規模 中国のバイオリアクター市場規模 インドのバイオリアクター市場規模 韓国のバイオリアクター市場規模 台湾のバイオリアクター市場規模 ... - ヨーロッパ/中東/アフリカのバイオリアクター市場規模 イギリスのバイオリアクター市場規模 ドイツのバイオリアクター市場規模 フランスのバイオリアクター市場規模 ロシアのバイオリアクター市場規模 ... - その他地域のバイオリアクター市場規模 ・競争状況 ・企業情報 |
The Global Bioreactors Market size was estimated at USD 1,571.95 million in 2021 and expected to reach USD 1,717.08 million in 2022, and is projected to grow at a CAGR 9.37% to reach USD 2,691.64 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Bioreactors to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Usage, the market was studied across Full-scale Production, Lab-Scale Production, and Pilot-scale Production.
Based on Control Type, the market was studied across Automated and Manual.
Based on Material, the market was studied across Glass and Stainless Steel.
Based on Scale, the market was studied across 1500L-4000L, 200L-1500L, 20L-200L, 5L-20L, and Above 4000L.
Based on Usability, the market was studied across Reusable and Single-use.
Based on Mechanism, the market was studied across Airlift Bioreactors, Benchtop Bioreactors, Bubble Column Bioreactors, Continuous Stirred Tank Bioreactors, Fluidized Bed Bioreactors, Microbial Bioreactors, Multi-Parallel Bioreactors, Packed Bed Bioreactors, and Photo-Bioreactors.
Based on Distrbution, the market was studied across Engineering, Procurement, and Construction Companies and OEMs.
Based on End User, the market was studied across Biopharmaceutical Companies & Manufacturers, Contract Manufacturing Organizations, Contract Research Organizations, Landfills, and R&D Departments & Institutes.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Bioreactors market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bioreactors Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Bioreactors Market, including 3D Biotek LLC, Applikon Biotechnology BV, BBI-Biotech GmbH, Bioengineering AG, Broadley-James Corporation, Cell Culture Company, Cytiva, Eppendorf AG, GEA Group AG, Infors AG, Merck KGaA, Pall Corporation, Pierre Guérin SAS, Praj Hipurity Systems Limited, Sartorius AG, Solaris Biotechnology Srl, Solida Biotech GmBH, Thermo Fisher Scientific Inc., and ZETA Holding GmbH.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Bioreactors Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bioreactors Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bioreactors Market?
4. What is the competitive strategic window for opportunities in the Global Bioreactors Market?
5. What are the technology trends and regulatory frameworks in the Global Bioreactors Market?
6. What is the market share of the leading vendors in the Global Bioreactors Market?
7. What modes and strategic moves are considered suitable for entering the Global Bioreactors Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid Growth of Biopharmaceuticals and Biologics Industry
5.1.1.2. Technology Advancements in Bioreactors
5.1.1.3. Adoption of Single-Use Bioreactors (subs) and Hybrid Bioreactors
5.1.1.4. Increasing Demand for Personalized Medicines
5.1.2. Restraints
5.1.2.1. Low Capacity of Single use Bioreactor or Disposable Bioreactor
5.1.2.2. Concerns Regarding Extrables and/or Leachables
5.1.3. Opportunities
5.1.3.1. High Market Potential in Emerging Economies
5.1.3.2. Rising Demand for Personalized Medicine
5.1.4. Challenges
5.1.4.1. Stringent Regulatory Framework
5.2. Cumulative Impact of COVID-19
6. Bioreactors Market, by Usage
6.1. Introduction
6.2. Full-scale Production
6.3. Lab-Scale Production
6.4. Pilot-scale Production
7. Bioreactors Market, by Control Type
7.1. Introduction
7.2. Automated
7.3. Manual
8. Bioreactors Market, by Material
8.1. Introduction
8.2. Glass
8.3. Stainless Steel
9. Bioreactors Market, by Scale
9.1. Introduction
9.2. 1500L-4000L
9.3. 200L-1500L
9.4. 20L-200L
9.5. 5L-20L
9.6. Above 4000L
10. Bioreactors Market, by Usability
10.1. Introduction
10.2. Reusable
10.3. Single-use
11. Bioreactors Market, by Mechanism
11.1. Introduction
11.2. Airlift Bioreactors
11.3. Benchtop Bioreactors
11.4. Bubble Column Bioreactors
11.5. Continuous Stirred Tank Bioreactors
11.6. Fluidized Bed Bioreactors
11.7. Microbial Bioreactors
11.8. Multi-Parallel Bioreactors
11.9. Packed Bed Bioreactors
11.10. Photo-Bioreactors
12. Bioreactors Market, by Distrbution
12.1. Introduction
12.2. Engineering, Procurement, and Construction Companies
12.3. OEMs
13. Bioreactors Market, by End User
13.1. Introduction
13.2. Biopharmaceutical Companies & Manufacturers
13.3. Contract Manufacturing Organizations
13.4. Contract Research Organizations
13.5. Landfills
13.6. R&D Departments & Institutes
14. Americas Bioreactors Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Bioreactors Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Bioreactors Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
18.1. 3D Biotek LLC
18.1.1. Business Overview
18.1.2. Key Executives
18.1.3. Product & Services
18.2. Applikon Biotechnology BV
18.2.1. Business Overview
18.2.2. Key Executives
18.2.3. Product & Services
18.3. BBI-Biotech GmbH
18.3.1. Business Overview
18.3.2. Key Executives
18.3.3. Product & Services
18.4. Bioengineering AG
18.4.1. Business Overview
18.4.2. Key Executives
18.4.3. Product & Services
18.5. Broadley-James Corporation
18.5.1. Business Overview
18.5.2. Key Executives
18.5.3. Product & Services
18.6. Cell Culture Company
18.6.1. Business Overview
18.6.2. Key Executives
18.6.3. Product & Services
18.7. Cytiva
18.7.1. Business Overview
18.7.2. Key Executives
18.7.3. Product & Services
18.8. Eppendorf AG
18.8.1. Business Overview
18.8.2. Key Executives
18.8.3. Product & Services
18.9. GEA Group AG
18.9.1. Business Overview
18.9.2. Key Executives
18.9.3. Product & Services
18.10. Infors AG
18.10.1. Business Overview
18.10.2. Key Executives
18.10.3. Product & Services
18.11. Merck KGaA
18.11.1. Business Overview
18.11.2. Key Executives
18.11.3. Product & Services
18.12. Pall Corporation
18.12.1. Business Overview
18.12.2. Key Executives
18.12.3. Product & Services
18.13. Pierre Guérin SAS
18.13.1. Business Overview
18.13.2. Key Executives
18.13.3. Product & Services
18.14. Praj Hipurity Systems Limited
18.14.1. Business Overview
18.14.2. Key Executives
18.14.3. Product & Services
18.15. Sartorius AG
18.15.1. Business Overview
18.15.2. Key Executives
18.15.3. Product & Services
18.16. Solaris Biotechnology Srl
18.16.1. Business Overview
18.16.2. Key Executives
18.16.3. Product & Services
18.17. Solida Biotech GmBH
18.17.1. Business Overview
18.17.2. Key Executives
18.17.3. Product & Services
18.18. Thermo Fisher Scientific Inc.
18.18.1. Business Overview
18.18.2. Key Executives
18.18.3. Product & Services
18.19. ZETA Holding GmbH
18.19.1. Business Overview
18.19.2. Key Executives
18.19.3. Product & Services
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing